1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Cyprotex PLC

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1999

Location

Cheshire UK

Primary Industry

Pharmaceuticals

About

Established in 1999 and based in Cheshire, UK, Cyprotex PLC operates as a contract research organization that offers a wide range of ADME Tox services such as in vitro toxicology testing, ADME screening, ADME assays and ADME predictive modeling.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.cyprotex.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only

Deals

Deals Type
Trade Sale
PIPE
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Cyprotex PLC 15 Dec 2016
Completed Cyprotex PLC 01 Sep 2013
Displaying 1-2 of 2

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.